IQ-AI Limited ( (GB:IQAI) ) just unveiled an announcement.
IQ-AI Limited has announced a successful placement to raise £250,000 through the issuance of 25,000,000 new ordinary shares, with the proceeds earmarked for clinical trials and the expansion of their marketing and sales teams. This strategic move is expected to bolster the company’s growth and strengthen its market position, with Braveheart Investment Group plc increasing its stake to 29.35% of the enlarged share capital.
More about IQ-AI Limited
IQ-AI Limited, the parent company of Imaging Biometrics, LLC, is focused on providing quantitative imaging platforms and therapeutics aimed at enhancing the efficiency and effectiveness of clinical diagnosis and treatment.
Average Trading Volume: 549,671
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £3.1M
Learn more about IQAI stock on TipRanks’ Stock Analysis page.